From the Editor
From the Editor
A new option for chemoprevention of invasive breast cancer
STAR trial studied a galaxy of SERM effects
From the Editor
Estrogen treatment: Safe and effective in early menopause
But many unanswered questions persist
From the Editor
How many days does it take you to pay for your liability insurance?
For ObGyns, the cost-to-revenue ratio is a worst-case scenario
From the Editor
A life-extending advance in treatment of ovarian cancer
Surgical cytoreduction followed by intravenous plus intraperitoneal chemotherapy is likely to become the standard of care for stage III ovarian...
From the Editor
Minimally invasive hysterectomy: We are at the tipping point
We could safely double the percentage of laparoscopic operations, but only if surgeons and hospitals are ready for change
From the Editor
The pipeline runneth over
HPV vaccine is next in a long line of new drugs that will change women’s health care more than anything since the Pap test.
From the Editor
Massive obstetric hemorrhage: High- and low-tech tools
Smart bombs, carpet bombs, and balloons
From the Editor
Does male circumcision cut risk of HIV infection?
For the first time, a surgical intervention study attests to a link. What do we tell new parents?
From the Editor
Decline of clomiphene for PCOS-related infertility
Metformin and aromatase inhibitors may promise fewer spontaneous abortions and multiple gestations
From the Editor
Repeat cesarean again and again and again
As 4th cesarean sections become more common, we are challenged to prevent adverse outcomes.
From the Editor
Testosterone patch: The road not taken
Androgens in OTC and off-label drugs may be less rigorously tested and effective than the testosterone patch for treating hypoactive desire in...